Generico
St. Louis, US · Founded 2013 · Missouri LLC · 2 known investors
Founders & leadership
SZ
Shu ZhuExecutive
TB
Thomas BryaExecutive
MG
Michael GrimshawExecutive
PV
Philip VogtExecutive
Board
DB
Dan BroderickBoard director
Investors · 2
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 1 round · 2015
▶$3.8MraisedJul 2015 · 21 investors · PharmaceuticalsRule 506(b)
▶$3.8MraisedJul 2015 · 21 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Shu ZhuExecutive Officer, Director
- Thomas BryaExecutive Officer, Director
- Dan BroderickDirector
- Michael GrimshawExecutive Officer, Director
- Philip VogtExecutive Officer, Director
- Offering amount
- $6.3M
- Amount sold
- $3.8M
- Minimum investment
- $1
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Missouri, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who are Generico's investors?
- Generico's investors include Alteria Capital, Lightbox.
- How much funding has Generico raised?
- Generico has disclosed $3.8M raised across 1 round.
- Where is Generico headquartered?
- Generico is headquartered in St. Louis, US.